TrCla4 promotes actin polymerization at the hyphal tip and mycelial growth in Trichophyton rubrum

Area of Science:

• Mycology
• Medicinal Chemistry
• Molecular Biology

Background:

• Superficial fungal infections like athlete's foot are common, affecting over 10% globally and impacting quality of life.
• Limited antifungal drug targets exist compared to bacterial infections, necessitating novel therapeutic strategies.
• Treatment-resistant fungal strains pose a growing concern, highlighting the need for new antifungal agents.

Purpose of the Study:

• To investigate the role of fungal PAK (p21-activated kinase) in the growth and morphology of Trichophyton rubrum.
• To evaluate fungal PAK as a potential therapeutic target for developing new antifungal treatments.

Main Methods:

• Generated a deletion strain (∆Trcla4) of the PAK gene TrCla4 in Trichophyton rubrum.
• Assessed the phenotypic changes in the ∆Trcla4 strain, including mycelial growth and hyphal morphology.
• Tested the efficacy of small chemical inhibitors of mammalian PAK (IPA-3 and FRAX486) on fungal proliferation.

Main Results:

• The ∆Trcla4 strain exhibited significant deficiencies in mycelial growth and altered hyphal morphology.
• Polarized actin localization at the hyphal tip was disrupted in the absence of TrCla4.
• Chemical inhibitors IPA-3 and FRAX486 effectively limited fungal mycelial proliferation.

Conclusions:

• Fungal PAKs, specifically TrCla4 in Trichophyton rubrum, play a critical role in essential fungal processes like growth and morphology.
• Fungal PAKs represent promising therapeutic targets for the development of novel antifungal medications.
• Inhibitors targeting fungal PAKs demonstrate potential for combating superficial fungal infections.